Tone mix
Week by week 29 weeks
Share of Evommune, Inc.'s 78 headlines over the last 31 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Mar 9, 2026 · tone -100Evommune (NYSE:EVMN) Posts Quarterly Earnings Results, Misses Expectations By $0.61 EPS-145
- Week of Jul 27, 2026 · tone +95Evommune begins Phase IIb trial of EVO756 for migraine+108
- Week of Oct 12, 2026 · tone +97Evommune (NYSE:EVMN) Upgraded at UBS Group+104
- Week of Dec 8, 2025 · tone 0Evommune (NYSE:EVMN) Issues Quarterly Earnings Results-61
- Week of Dec 22, 2025 · tone 0Evommune (EVMN) Stock Price, Quote, News & History-60
- Week of Feb 16, 2026 · tone 0Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Evommune (NYSE:EVMN), Gilat Satellite Networks (NASDAQ:GILT), Lyft (NASDAQ:LYFT), Transocean (NYSE:RIG)-52
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Evommune, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | 0 |
| Last 30 sessions | 5 | +20 |
| Last 90 sessions | 34 | -15 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 2 outletsEvommune (NYSE:EVMN) Coverage Initiated by Analysts at Morgan StanleyNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Evommune (NYSE:EVMN) Coverage Initiated by Analysts at Morgan Stanley | www.dailypolitical.com | 2 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
2 headlines, average tone +97: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletEvommune (NYSE:EVMN) Upgraded at UBS GroupPositive
- www.tickerreport.com · 1 outletEvommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS GroupPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Evommune (NYSE:EVMN) Upgraded at UBS Group | www.dailypolitical.com | 1 | Positive |
| Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS Group | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 1, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletEvommune, Inc.: Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology CongressNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Evommune, Inc.: Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology Congress | www.finanznachrichten.de | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, September 18, 2026
1 headline, average tone -96: 0 positive, 0 neutral and 1 negative. Showing all 1.
- finance.yahoo.com · 1 outletEvommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline?Negative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Evommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline? | finance.yahoo.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, September 17, 2026
3 headlines, average tone -32: 0 positive, 2 neutral and 1 negative. Showing all 3.
- www.insidermonkey.com · 1 outletEvommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline?Negative
- www.themarketsdaily.com · 1 outletEvommune (EVMN) & The Competition Head-To-Head ComparisonNeutral
- www.dailypolitical.com · 1 outletHead-To-Head Comparison: Evommune (EVMN) versus Its CompetitorsNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Evommune (EVMN) Drops EVO756 for Eczema. Can EVO301 Carry the Pipeline? | www.insidermonkey.com | 1 | Negative |
| Evommune (EVMN) & The Competition Head-To-Head Comparison | www.themarketsdaily.com | 1 | Neutral |
| Head-To-Head Comparison: Evommune (EVMN) versus Its Competitors | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Evommune, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.